Shalini R: Not All Blood Thinners Are the Same
Shalini R, Registered Nurse at Saudi German Health, shared a post on LinkedIn:
”Notes:10
Not all ‘blood thinners’ are the same – and understanding the difference is key to safer prescribing and better patient outcomes.
This visual highlights the distinction between anticoagulants and antiplatelet agents, two major classes that reduce clot formation through different mechanisms:
Anticoagulants (e.g., warfarin, apixaban, rivaroxaban, dabigatran)
- Work on the coagulation cascade to slow down clot formation
- Commonly used in conditions like atrial fibrillation, DVT, and PE
- Require careful monitoring (especially warfarin)
- Associated with a higher bleeding risk
Antiplatlet drugs (e.g., aspirin, clopidogrel, ticagrelor, prasugrel)
- Prevent platelets from aggregating and forming clots
- Primarily used in arterial disease (e.g., coronary artery disease, stroke prevention)
- Typically lower bleeding risk compared to anticoagulants
Key takeaway:
Anticoagulants target the clotting cascade, while antiplatelets target platelet function-choosing the right class depends on the underlying pathology.
A simple concept, but one that makes a critical difference in clinical decision-making.”
Stay updated with Hemostasis Today.
-
Jul 23, 2026, 14:32Saneha Anjum Shaikh: Why Antibody Screening Must Be Standard Practice in Modern Blood Banking
-
Jul 23, 2026, 14:00Ron Vezina: Canadian Blood Services Issues Urgent Donation Appeal
-
Jul 23, 2026, 13:46Sebastian Szmit: Understanding Troponins in Modern Cardio-Oncology
-
Jul 23, 2026, 13:41Colleen Grady: Why Normal Hemoglobin Does Not Exclude Iron Deficiency
-
Jul 23, 2026, 13:22Jacob Kelly: AHA Review Highlights Coffee’s Cardiovascular Benefits
-
Jul 23, 2026, 13:01Sally Mandour: Automated Blood Indices Enhance IDA Diagnosis in Cirrhotic Patients
-
Jul 23, 2026, 12:42Eva Pavlidou: A Memorable First ISTH Experience
-
Jul 23, 2026, 10:33Johanna Rodríguez: The Structural Challenge of Next-Gen Anticoagulants
-
Jul 23, 2026, 10:27Logan Hamilton: New Study Identifies the Mutated Antibody Gene Responsible for VITT